[SCHEDULE 13G/A] AirSculpt Technologies, Inc. SEC Filing

Rhea-AI Filing Summary

AirSculpt Technologies, Inc. Schedule 13G/A discloses that a group led by Vesey Street holds a large, concentrated position in the company’s common stock (CUSIP 009496100). The filing reports that Adam T. Feinstein and affiliated entities together hold 30,324,180 shares, or 48.6% of the outstanding common stock. Ownership is allocated across entities: VSCP EBS Aggregator, L.P. (14,038,819 shares, 22.5%), Vesey Street Capital Partners Healthcare Fund-A, L.P. (4,523,899 shares, 7.2%), and EBS Aggregator Blocker Holdings, LLC (11,761,462 shares, 18.8%).

The reporting persons state they possess shared voting and dispositive power over these shares while asserting no sole voting or dispositive power. The percentage calculations are stated to be based on 62,436,670 shares outstanding as of July 31, 2025, per the issuer’s unaudited condensed consolidated financial statements. The filing explains Mr. Feinstein’s management roles through the Vesey Street organizational structure and notes that each reporting person disclaims beneficial ownership beyond its pecuniary interest.

Positive

• Significant, clearly disclosed ownership positions provide transparency: 30,324,180 shares total (48.6% of class) across reporting persons.
• Allocation by entity is specified, showing 14,038,819 shares for VSCP EBS Aggregator, L.P., 11,761,462 shares for EBS Aggregator Blocker Holdings, LLC, and 4,523,899 shares for Vesey Street Capital Partners Healthcare Fund-A, L.P.

Negative

• Highly concentrated ownership (48.6%) may raise governance and minority-shareholder influence concerns due to the group’s potential to control votes.
• Voting and dispositive power are reported as shared rather than sole, but holdings are organized across affiliated entities managed by the same party, which could centralize practical control.

Insights

Financial Analyst

TL;DR: Vesey Street-affiliated holders control nearly half of AirSculpt’s stock, creating clear shareholder influence but not an explicit single-party sole control.

The Schedule 13G/A shows a concentrated stake equal to 48.6% of outstanding shares held across related entities, with shared voting and dispositive power and zero reported sole power. For investors, this concentration materially increases the group’s ability to influence board composition and major corporate actions without demonstrating unilateral sole control. The filing confirms the ownership basis on 62,436,670 shares outstanding, clarifying the percentage math. The disclosure of managed relationships and the disclaimer limiting beneficial ownership to pecuniary interest are standard legal structures that frame but do not eliminate the group’s practical influence.

Corporate Governance Expert

TL;DR: A related-party ownership structure led by Adam Feinstein yields material governance influence, raising typical minority-protection considerations.

The reported 48.6% consolidated position across affiliated entities is immediately material for governance and strategic direction. Shared voting power across multiple vehicles under a common manager suggests coordinated decision-making potential; the filing also documents the organizational links and the manager role of Mr. Feinstein. While the reporting persons disclaim beneficial ownership beyond pecuniary interest, that legal language does not negate the operational effect of near-majority ownership on shareholder votes and corporate initiatives. This is an impactful disclosure for holders evaluating corporate control dynamics.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Airsculpt Technologies, Inc.

(Name of Issuer)

Common Stock, $0.001 par value per share

(Title of Class of Securities)

009496100

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 009496100

1

Names of Reporting Persons

EBS Aggregator Blocker Holdings, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 11,761,462.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 11,761,462.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

11,761,462.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

18.8 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: Row (6), (8), and (9): Consists of 11,761,462 shares of Common Stock held directly by EBS Aggregator Blocker Holdings, LLC. Row (11): This percentage is calculated based on 62,436,670 shares of Common Stock outstanding as of July 31, 2025, as set forth in the Issuer's Unaudited Condensed Consolidated Financial Statements for the period ended June 30, 2025, filed with the Securities and Exchange Commission on August 1, 2025.

SCHEDULE 13G

CUSIP No. 009496100

1

Names of Reporting Persons

Adam T Feinstein

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 30,324,180.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 30,324,180.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

30,324,180.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

48.6 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: Row (6), (8), and (9): Consists of 14,038,819 shares of Common Stock held directly by VSCP EBS Aggregator, L.P., a Delaware limited partnership, 4,523,899 shares of Common Stock held directly by Vesey Street Capital Partners Healthcare Fund-A, L.P., a Delaware limited partnership, and 11,761,462 shares of Common Stock held directly by EBS Aggregator Blocker Holdings, LLC, a Delaware limited liability company. Mr. Feinstein serves as managing partner of Vesey Street Capital Partners, L.L.C., a Delaware limited liability company, which is the general partner of Vesey Street Capital Partners Healthcare GP, L.P., a Delaware limited partnership, which serves as the general partner of VSCP EBS Aggregator, L.P. and Vesey Street Capital Partners Healthcare Fund-A, L.P. and the manager of EBS Aggregator Blocker Holdings, LLC. Row (11): This percentage is calculated based on 62,436,670 shares of Common Stock outstanding as of July 31, 2025, as set forth in the Issuer's Unaudited Condensed Consolidated Financial Statements for the period ended June 30, 2025, filed with the Securities and Exchange Commission on August 1, 2025.

SCHEDULE 13G

CUSIP No. 009496100

1

Names of Reporting Persons

VSCP EBS Aggregator, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 14,038,819.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 14,038,819.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

14,038,819.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

22.5 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: Row (6), (8), and (9): Consists of 14,038,819 shares of Common Stock held directly by VSCP EBS Aggregator, L.P. Row (11): This percentage is calculated based on 62,436,670 shares of Common Stock outstanding as of July 31, 2025, as set forth in the Issuer's Unaudited Condensed Consolidated Financial Statements for the period ended June 30, 2025, filed with the Securities and Exchange Commission on August 1, 2025.

SCHEDULE 13G

CUSIP No. 009496100

1

Names of Reporting Persons

Vesey Street Capital Partners Healthcare Fund-A, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,523,899.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,523,899.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,523,899.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.2 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: Row (6), (8), and (9): Consists of 4,523,899 shares of Common Stock held directly by Vesey Street Capital Partners Healthcare Fund-A, L.P. Row (11): This percentage is calculated based on 62,436,670 shares of Common Stock outstanding as of July 31, 2025, as set forth in the Issuer's Unaudited Condensed Consolidated Financial Statements for the period ended June 30, 2025, filed with the Securities and Exchange Commission on August 1, 2025.

SCHEDULE 13G

CUSIP No. 009496100

1

Names of Reporting Persons

Vesey Street Capital Partners, L.L.C.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 30,324,180.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 30,324,180.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

30,324,180.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

48.6 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: Row (6), (8), and (9): Consists of 14,038,819 shares of Common Stock held directly by VSCP EBS Aggregator, L.P., a Delaware limited partnership, 4,523,899 shares of Common Stock held directly by Vesey Street Capital Partners Healthcare Fund-A, L.P., a Delaware limited partnership, and 11,761,462 shares of Common Stock held directly by EBS Aggregator Blocker Holdings, LLC, a Delaware limited liability company. Mr. Feinstein serves as managing partner of Vesey Street Capital Partners, L.L.C., a Delaware limited liability company, which is the general partner of Vesey Street Capital Partners Healthcare GP, L.P., a Delaware limited partnership, which serves as the general partner of VSCP EBS Aggregator, L.P. and Vesey Street Capital Partners Healthcare Fund-A, L.P. and the manager of EBS Aggregator Blocker Holdings, LLC. Row (11): This percentage is calculated based on 62,436,670 shares of Common Stock outstanding as of July 31, 2025, as set forth in the Issuer's Unaudited Condensed Consolidated Financial Statements for the period ended June 30, 2025, filed with the Securities and Exchange Commission on August 1, 2025.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Airsculpt Technologies, Inc.
(b)	Address of issuer's principal executive offices: c/o AirSculpt Technologies, Inc., 1111 Lincoln Road, Suite 802, Miami Beach, Florida 33139
Item 2.
(a)	Name of person filing: The persons filing this statement are Adam T Feinstein, VSCP EBS Aggregator, L.P., Vesey Street Capital Partners Healthcare Fund-A, L.P., EBS Aggregator Blocker Holdings, LLC, and Vesey Street Capital Partners, L.L.C. Together, Adam T Feinstein, VSCP EBS Aggregator, L.P., Vesey Street Capital Partners Healthcare Fund-A, L.P., EBS Aggregator Blocker Holdings, LLC, and Vesey Street Capital Partners, L.L.C. are the "Reporting Persons."
(b)	Address or principal business office or, if none, residence: c/o AirSculpt Technologies, Inc. 1111 Lincoln Road, Suite 802 Miami Beach, Florida 33139
(c)	Citizenship: Adam Feinstein is a United States citizen. VSCP EBS Aggregator, L.P. is a Delaware limited partnership. Vesey Street Capital Partners Healthcare Fund-A, L.P. is a Delaware limited partnership. EBS Aggregator Blocker Holdings, LLC is a Delaware limited liability company. Vesey Street Capital Partners, L.L.C. is a Delaware limited liability company.
(d)	Title of class of securities: Common Stock, $0.001 par value per share
(e)	CUSIP No.: 009496100
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See Exhibit 99.2 hereto.
(b)	Percent of class: See Exhibit 99.2 hereto.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See Exhibit 99.2 hereto.
	(ii) Shared power to vote or to direct the vote: See Exhibit 99.2 hereto.
	(iii) Sole power to dispose or to direct the disposition of: See Exhibit 99.2 hereto.
	(iv) Shared power to dispose or to direct the disposition of: See Exhibit 99.2 hereto.
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Mr. Feinstein may be deemed to beneficially own, and have voting and dispositive power over, the shares of Common Stock held by VSCP EBS Aggregator, L.P., EBS Aggregator Blocker Holdings, LLC, and Vesey Street Capital Partners Healthcare Fund-A, L.P. through his role as managing partner of Vesey Street Capital Partners, L.L.C., which serves as the general partner of Vesey Street Capital Partners Healthcare GP, L.P., which serves as general partner or manager of each of the entities holding Common Stock. Each of the Reporting Persons disclaims beneficial ownership of any securities that exceed its pecuniary interest therein.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

EBS Aggregator Blocker Holdings, LLC

Signature:	/s/ Adam T. Feinstein
Name/Title:	Authorized Signatory
Date:	08/08/2025

Adam T Feinstein

Signature:	/s/ Adam T. Feinstein
Name/Title:	Adam T. Feinstein
Date:	08/08/2025

VSCP EBS Aggregator, L.P.

Signature:	/s/ Adam T. Feinstein
Name/Title:	Authorized Signatory
Date:	08/08/2025

Vesey Street Capital Partners Healthcare Fund-A, L.P.

Signature:	/s/ Adam T. Feinstein
Name/Title:	Adam T. Feinstein
Date:	08/08/2025

Vesey Street Capital Partners, L.L.C.

Signature:	/s/ Adam T. Feinstein
Name/Title:	Authorized Signatory
Date:	08/08/2025

Exhibit Information

Exhibit 99.1 - Joint Filing Agreement (incorporated herein by reference to Exhibit 99.1 to the Schedule 13G filed with the SEC by the Reporting Persons on February 11, 2022) Exhibit 99.2 - Additional Information

FAQ

Who filed the Schedule 13G/A reporting large holdings in AirSculpt (AIRS)?

The filing was made by Adam T. Feinstein and affiliated entities: VSCP EBS Aggregator, L.P.; Vesey Street Capital Partners Healthcare Fund-A, L.P.; EBS Aggregator Blocker Holdings, LLC; and Vesey Street Capital Partners, L.L.C.

How many AirSculpt shares does the Vesey Street group report owning and what percent is that of AIRS?

The group reports beneficial ownership of 30,324,180 shares, representing 48.6% of the outstanding common stock on the basis of 62,436,670 shares outstanding.

Does any reporting person claim sole voting or dispositive power over AIRS shares?

No. Each reporting person reports 0 sole voting power and 0 sole dispositive power, with the disclosed holdings reflected as shared voting and shared dispositive power.

What entity holds 11,761,462 AIRS shares and what percent does that represent?

EBS Aggregator Blocker Holdings, LLC holds 11,761,462 shares, representing 18.8% of the class as stated in the filing.

On what share count is the ownership percentage based?

The percentages are calculated based on 62,436,670 shares of common stock outstanding as of July 31, 2025, per the issuer’s unaudited condensed consolidated financial statements referenced in the filing.